iShares US Medical Devices

Latest iShares US Medical Devices News and Updates

  • uploads///eps
    Earnings Report

    What to Expect from St. Jude Medical’s Earnings in 2Q16

    In 1Q16, St. Jude Medical exceeded analysts’ EPS (earnings per share) estimate of $0.89 as well as the revenue estimate of ~$1.4 billion.

    By Sarah Collins
  • uploads///kyle sterk  unsplash
    Company & Industry Overviews

    ALGN Stock Surpasses the S&P 500 Index’s Year-to-Date Gain

    On September 28, Align Technology (ALGN) posted an ~74% increase year-to-date. In the same period, the S&P 500 Index has returned ~9%.

    By Sarah Collins
  • uploads///STOCK PRICE
    Company & Industry Overviews

    Abbott Laboratories Traded at a 52-Week High after Posting Strong 4Q17 Results

    On January 29, 2018, Abbott Laboratories (ABT) closed trading at $63.31 per share. The company reported its 52-week high of $64.60 on January 25.

    By Sarah Collins
  • uploads///core strategies
    Company & Industry Overviews

    How Are Stryker’s Core Strategies Working Toward Its Growth?

    Stryker (SYK) registered strong 3Q16 earnings on October 27, 2016. The company’s reported earnings exceeded analysts’ estimates.

    By Sarah Collins
  • uploads///STOCK PRICE
    Company & Industry Overviews

    BD’s Stock Price Performance after Recent 52-Week High

    On December 28, Becton, Dickinson and Company (BDX), or BD, closed trading on the day at $214.32 per share. Currently, BD stock’s 50-day moving average stands at $221.22.

    By Sarah Collins
  • uploads///stock price
    Company & Industry Overviews

    Abbott Laboratories’ Stock Performance after a Recent Bull Run

    On February 16, Abbott Laboratories (ABT) closed trading at $60.17 per share.

    By Sarah Collins
  • uploads///stock performance
    Earnings Report

    Abbott Laboratories’ Stock Price Performance in July

    Year-to-date, ABT stock has risen 12.8%. Over the last month, the stock has returned ~4.0%.

    By Sarah Collins
  • uploads///STOCK PRICE
    Company & Industry Overviews

    How Has Boston Scientific Stock Performed Recently?

    Boston Scientific (BSX) was trading at $27.9 on June 29, 2017.

    By Sarah Collins
  • uploads///hand __
    Company & Industry Overviews

    BSX Stock Regains Momentum after Its Recent Bearish Trend

    On February 14, 2018, Boston Scientific stock closed the day at $26.81. The stock was trading near its 50-day moving average of $26.82.

    By Sarah Collins
  • uploads///revenue estimates
    Company & Industry Overviews

    Stryker’s Recent Stock Price Movement: Upside Potential?

    Stryker stock has registered slightly volatile activity in the past few months. However, the stock largely remains on a bullish trajectory.

    By Sarah Collins
  • uploads///STOCK PRICE
    Earnings Report

    A Look at Medtronic’s Recent Stock Performance

    Medtronic (MDT) was trading at $83.9 on May 22, 2017. It had a 50-day moving average of $82.1 and a 200-day moving average of $78.4.

    By Sarah Collins
  • uploads///COMPLEMENTARY PORTFOLIO
    Company & Industry Overviews

    Effect of Claris Injectables Acquisition on Baxter’s 2017 Growth

    On July 27, 2017, Baxter International (BAX) completed the acquisition of Claris Injectables, which is expected to help expand and strengthen Baxter’s core capabilities.

    By Sarah Collins
  • Healthcare

    Must-know: Key export barriers for medical device manufacturers

    Most large U.S. manufacturers have invested significant capital into emerging markets, including Medtronics, Johnson & Johnson, GE, and Stryker.

    By Amritpal Khalsa
  • uploads///microbiology _
    Company & Industry Overviews

    Illumina Stock Continues Its Bull Run

    Illumina (ILMN) reached a 52-week high of $357.93 per share on August 31.

    By Sarah Collins
  • Industrials

    Brazil’s medical device industry: Health coverage outlook

    The upward trends of the healthcare market show that Brazil is positive for the medical device industry, suggesting rapid increases in demand as more and more people can afford the devices and pay accordingly.

    By Amritpal Khalsa
  • uploads///eps estimates
    Earnings Report

    What Can We Expect for Stryker’s Earnings in 2Q16?

    In 1Q16, Stryker exceeded analysts’ EPS (earnings per share) estimate of $1.20, as well as the revenue estimate of ~$2.5 billion.

    By Sarah Collins
  • uploads///MDT net income
    Company & Industry Overviews

    A Look at Medtronic’s Earnings Trends and Guidance for Fiscal 2019

    Medtronic (MDT) reported net income of $1.1 billion in the second quarter of fiscal 2019 compared to $2.0 billion in the second quarter of fiscal 2018.

    By Daniel Collins
  • uploads///RTG
    Company & Industry Overviews

    How Does Medtronic’s Restorative Therapies & Diabetes Group Look?

    Medtronic’s Restorative Therapies Group consists of Spine, Brain, Specialty and Pain therapies.

    By Daniel Collins
  • uploads///BSX
    Company & Industry Overviews

    Why Analysts Are Mostly Positive on Boston Scientific Stock

    Boston Scientific stock rose from $24.79 at the close of market on December 29, 2017, to $34.80 at the close of market on November 23.

    By Daniel Collins
  • uploads///ISRG
    Company & Industry Overviews

    Intuitive Surgical Stock Has Seen Growth of 34% Year-to-Date

    Intuitive Surgical’s stock price rose from $364.94 at the close of market on December 29, 2017, to $489.57 on November 23, 2018.

    By Daniel Collins
  • uploads///lab _
    Earnings Report

    Thermo Fisher Beats Analysts’ Estimates in Q3 2018 Earnings

    Thermo Fisher Scientific (TMO) reported its third-quarter results today. It surpassed analysts’ estimates for EPS and revenue.

    By Mike Benson
  • uploads///Chart
    Earnings Report

    Thermo Fisher’s Third-Quarter Revenue Estimates

    The Life Sciences Solutions segment, including reagents, instruments, and consumables, contributes ~25% of Thermo Fisher’s total revenues.

    By Mike Benson
  • uploads///hospital _
    Earnings Report

    Zimmer Biomet Holdings: Revenue Trends ahead of Its Q3 Earnings

    Zimmer Biomet (ZBH) plans to release its Q3 earnings on October 26. Analysts expect ZBH to generate third-quarter revenues of $1.8 billion.

    By Daniel Collins
  • uploads///COMPARISON
    Company & Industry Overviews

    EW Stock Returned More than the S&P 500’s Gain in 2018

    As of September 28, Edwards Lifesciences (EW) has registered a rise of ~52.5% YTD (year-to-date). In the same period, the S&P 500 has risen ~9.2%.

    By Sarah Collins
  • uploads///COMPARISON
    Company & Industry Overviews

    ABT Returns Almost Double the S&P 500’s Year-to-Date Gain

    As of September 19, Abbott Laboratories (ABT) has registered a rise of ~17% YTD (year-to-date).

    By Sarah Collins
  • uploads///chemist _
    Company & Industry Overviews

    How Thermo Fisher Scientific’s Valuation Looks in September

    Thermo Fisher Scientific currently trades at a forward PE multiple of ~19.9x.

    By Mike Benson
  • uploads///Chart
    Company & Industry Overviews

    What Analysts Expect for Abiomed

    Wall Street analysts estimate Abiomed (ABMD) will report 29.9% growth in revenues to ~$771.0 million in 2019 as compared to $593.7 million in 2018.

    By Mike Benson
  • uploads///stock price
    Company & Industry Overviews

    Reading Dentsply Sirona’s Recent Stock Performance

    On March 13, 2018, Dentsply Sirona closed trading at a price of $57.80 per share. The stock registered its 52-week high of $68.98 on November 28, 2017.

    By Sarah Collins
  • uploads///STOCK PRICE
    Company & Industry Overviews

    BSX Stock Rises More Than 2% Following EMcision Acquisition

    Boston Scientific’s recent stock performance On March 6, 2018, Boston Scientific (BSX) stock closed at $27.41, higher than its 50-day moving average of $27.15 and lower than its 200-day moving average of $27.52. As of March 7, 2018, Boston Scientific’s 52-week high was $29.93 on October 23, 2017, and its 52-week low was $24.02 on March 22, 2017. Factors […]

    By Sarah Collins
  • uploads///medtech growth comparison
    Company & Industry Overviews

    Where Is SYK Stock Headed after Its Recent All-Time Highs?

    On February 26, 2018, Stryker (SYK) closed trading at $165.77. The stock was trading at its all-time high of $170 on January 29, 2018.

    By Sarah Collins
  • uploads///recommendations
    Earnings Report

    What Analysts Recommend for Medtronic ahead of 3Q18 Earnings

    Medtronic (MDT) plans to release its 3Q18 earnings results on February 20, 2018.

    By Sarah Collins
  • uploads///conclusion of the contract __
    Company & Industry Overviews

    How BD Stock Has Performed in the Last Year

    On February 6, 2018, BD released its 1Q18 earnings results, which came in ahead of expectations.

    By Sarah Collins
  • uploads///ambulance _
    Earnings Report

    BD Medical Segment Posted Strong Fiscal 1Q18 Performance

    In fiscal 1Q18, BDX’s Medication and Procedural Solutions business registered sales growth of 5.0%.

    By Sarah Collins
  • uploads///DEAL RATIONALE
    Company & Industry Overviews

    Rationale behind Varian Medical’s Acquisition of Sirtex Medical

    On January 30, 2018, Varian Medical Systems (VAR) announced that it had entered into an agreement to acquire Sirtex Medical Limited for $1.3 billion.

    By Sarah Collins
  • uploads///STOCK PRICE
    Earnings Report

    ABT Stock Trading Near Its All-Time High: What’s Driving Growth?

    Abbott Laboratories (ABT) is currently trading near its all-time high of $59.60 per share, which was reported on January 4, 2018.

    By Sarah Collins
  • uploads///stock price
    Company & Industry Overviews

    Stryker’s Stock Rally Continues with 52-Week High Yesterday

    On January 9, Stryker (SYK) traded at a 52-week high of $164.2 per share. The stock ended trading with a closing price of $160.4.

    By Sarah Collins
  • uploads///STOCK PRICE
    Company & Industry Overviews

    Discussing Baxter International’s Recent Stock Price Highs

    On January 4, 2018, Baxter International was trading at a 52-week high of $68.86 per share, ending the day at $68.41 per share.

    By Sarah Collins
  • uploads///stock price
    Company & Industry Overviews

    A Look at Thermo Fisher Scientific’s Recent Stock Price Performance

    TMO stock reported its 52-week high of $201.20 on October 26, 2017, when the company released its 3Q17 earnings results.

    By Sarah Collins
  • uploads///product segments
    Company & Industry Overviews

    TMO’s Acquisition from EPTEK Technology Could Boost Its China Opportunity

    On December 4, 2017, Thermo Fisher Scientific (TMO) completed the acquisition of some assets from EPTEK Technology and related entities that have offices in mainland China and Taiwan.

    By Sarah Collins
  • uploads///GOP TAX BILL
    Healthcare

    How the Corporate Tax Rate Cut Could Affect R&D in the Medtech Industry

    The repeal of the tax deduction for high medical expenses may reduce the number of taxpayers opting for costly medical technologies and services.

    By Sarah Collins
  • uploads///STOCK PRICE
    Company & Industry Overviews

    Understanding BD’s Recent Stock Performance

    BD has a 50-day moving average of $197.25, while its 200-day moving average is $192.35.

    By Sarah Collins
  • uploads///EPS ESTIMATES
    Company & Industry Overviews

    Inside Baxter International’s Stock Price Performance

    On September 7, 2017, BAX stock closed at $62.84 per share. It has a 50-day moving average of $61.15 and a 200-day moving average of $57.14.

    By Sarah Collins
  • uploads///revenue guidance
    Company & Industry Overviews

    Edwards Lifesciences Near 52-Week High: Can It Sustain Momentum?

    Edwards Lifesciences (EW), a leader in the artificial heart valve market, has been expanding rapidly amid its new product launches and innovative product pipeline.

    By Sarah Collins
  • uploads///CATEGORY LEADERSHIP
    Company & Industry Overviews

    Boston Scientific Is Accelerating Category Leadership Strategy

    Boston Scientific (BSX) currently has a global market opportunity of $40.0 billion, which is expected to grow to $50.0 billion by fiscal 2020.

    By Sarah Collins
  • uploads///STOCK PRICE
    Company & Industry Overviews

    What’s Behind the Recent Slump in ZBH Stock Price?

    Zimmer Biomet closed trading at price of $113.1 on August 30. The stock has a 50-day moving average of $119.95 and a 200-day moving average of $120.95.

    By Sarah Collins
  • uploads///STOCK PRICE
    Company & Industry Overviews

    Taking a Look at Stryker’s Recent Stock Price Performance

    On August 31, Stryker (SYK) closed trading at a closing price of $139.3. It has a 50-day moving average of $144.7 and a 200-day moving average of $137.5.

    By Sarah Collins
  • uploads///services ecoomic value
    Company & Industry Overviews

    How Medtronic Is Accelerating Its Economic Value Growth Strategy

    Medtronic’s (MDT) Hospital Solutions segment registered double-digit growth in fiscal 1Q18.

    By Sarah Collins
  • uploads///PERFORMANCE
    Earnings Report

    Key Highlights of Varian Medical Systems’ Fiscal 2Q17 Earnings

    On April 26, 2016, Varian Medical Systems (VAR) released its 2Q17 earnings. VAR beat consensus estimates for revenues in 2Q17 by ~0.8% and reported in-line earnings per share.

    By Sarah Collins
  • uploads///STOCK
    Earnings Report

    Key Drivers behind BDX’s Recent Stock Performance

    BDX has a 50-day moving average of $196.80 and a 200-day moving average of $185.70.

    By Sarah Collins
  • uploads///eps estimates
    Earnings Report

    What to Expect from Intuitive Surgical’s 2Q17 Earnings

    Analysts estimate that Intuitive Surgical will post 2Q17 EPS (earnings per share) of ~$4.76. In 1Q17, Intuitive Surgical exceeded analysts’ diluted EPS estimate of $4.67.

    By Sarah Collins
  • uploads///STOCK
    Company & Industry Overviews

    Behind BD’s Recent New Stock Price High

    BD (BDX) closed trading at $195.3 on July 6, 2017, ahead of its 50-day moving average of $191.3 and its 200-day moving average of $181.9.

    By Sarah Collins
  • uploads///Chart  ABT
    Miscellaneous

    A Look at Abbott Laboratories Stock for 2Q17

    Wall Street analysts estimate that Abbott Laboratories (ABT) stock has the potential to return ~6.1% over the next 12 months.

    By Mike Benson
  • uploads///stock price
    Company & Industry Overviews

    Varian Medical Systems: Analyzing Its Stock Performance

    Varian Medical Systems (VAR) was trading at $102.7 on June 29, 2017. It has a 50-day moving average of $100.4 and a 200-day moving average of $88.8.

    By Sarah Collins
  • uploads///growth drivers
    Company & Industry Overviews

    FDA Warning Letter to Zimmer Biomet Resolved, Boosts Confidence

    On June 13, 2017, Zimmer Biomet (ZBH) announced that the FDA warning letter issued in June 2015 relating to its Zhejiang manufacturing facility in China has been closed.

    By Sarah Collins
  • uploads///Graph
    Miscellaneous

    Health Sector Overview: Week of June 5–9, 2017

    In the week ending June 9, 2017, the Health Care Select Sector SPDR Fund (XLV) saw a rise of 0.13%.

    By Margaret Patrick
  • uploads///stock
    Company & Industry Overviews

    Behind Thermo Fisher’s Recent Stock Performance

    TMO stock was trading at $173.2 on May 30, 2017. The stock had a 50-day moving average of $165.9 and a 200-day moving average of $153.8 that day.

    By Sarah Collins
  • uploads///STOCK PRICE
    Company & Industry Overviews

    How Zimmer Biomet Stock Has Performed Recently

    Zimmer Biomet Holdings (ZBH) was trading at $118.40 on May 30, 2017. It has a 50-day moving average of $119.70 and a 200-day moving average of $114.20.

    By Sarah Collins
  • uploads///margin
    Earnings Report

    Medtronic’s Strong 4Q17 Profits Beat Analyst Expectations

    Medtronic (MDT) reported an operating margin of 30.7% of total sales in fiscal 4Q17 on a constant currency basis.

    By Sarah Collins
  • uploads///recommendations
    Company & Industry Overviews

    What Do Analysts Recommend for Boston Scientific?

    Let’s look at Wall Street analysts’ recommendations and target prices for Boston Scientific (BSX) over the next 12 months.

    By Sarah Collins
  • uploads///CHART
    Macroeconomic Analysis

    Trump Trade Fades amid Political Debacle: What’s the Impact?

    As part of Obamacare, a medical device tax of 2.3% has been implemented on medical device companies in the United States.

    By Sarah Collins
  • uploads///recommendations
    Earnings Report

    What Analysts Recommend for Stryker after 1Q17 Results

    The consensus 12-month target price for Stryker is $141, a ~3.5% return potential.

    By Sarah Collins
  • uploads///abbott st jude
    Company & Industry Overviews

    FTC Approved Abbott’s Acquisition of St. Jude Medical

    The FTC (Federal Trade Commission) has approved the $25 billion acquisition of St. Jude Medical (STJ) by Abbott Laboratories (ABT) subject to certain conditions.

    By Sarah Collins
  • uploads///emerson industrial automation operating margins
    Company & Industry Overviews

    Not Much to Brag About for Emerson’s Industrial Automation Unit

    Revenues for Emerson’s Industrial Automation segment have fallen from $5.3 billion in 2011 to $4.1 billion in 2015.

    By Shannon Black
  • uploads///danaher diagnostics competitors
    Company & Industry Overviews

    How Danaher Diagnostics Fares against Its Competition

    Danaher’s Diagnostics unit had operating margins of 15.4% in 2015 and 17.2% in 1H16.

    By Shannon Black
  • uploads///Danaher Life Sciences unit
    Company & Industry Overviews

    Understanding the Skeleton of Danaher’s Life Sciences Business

    Customers in the Danaher life sciences business generally look at how the technology offered by a company can fit into their workflows.

    By Shannon Black
  • uploads///part
    Company & Industry Overviews

    How Are Danaher’s Returns Compared to Its Industry Peers’?

    Danaher’s ROIC fell steadily from 15.5% in 2006 to 8.5% in 2015, indicating that it has probably had fewer high return reinvestment opportunities since then.

    By Shannon Black
  • uploads///fin model
    Company & Industry Overviews

    Understanding Thermo Fisher Scientific’s Financial Model

    Thermo Fisher Scientific aims to deliver adjusted EPS in the range of $11.3–$12.2 by 2019. This represents a three-year CAGR of 12%–15%.

    By Sarah Collins
  • uploads///Part  Graph
    Company & Industry Overviews

    IHI’s Holdings: How Are Moving Averages Trending?

    As of June 2, 2016, 91% of IHI’s stocks were trading above their 20-day moving averages, 79% above their 50-day moving averages, and 89% above their 100-day moving averages.

    By Peter Neil
  • uploads///Part  Graph
    Company & Industry Overviews

    Profit Booking Leaves the iShares US Medical Devices ETF (IHI) in the Red

    On May 19, markets declined, with the SPDR S&P 500 ETF dropping by 0.3% and the iShares US Medical Devices ETF (IHI) declining by 0.8%.

    By Peter Neil
  • uploads/// App Economy
    Macroeconomic Analysis

    What’s behind the US Economy’s Remarkable Labor Market Strength?

    The US labor market has shown tremendous resilience amid concerns over various issues, like aging demographics.

    By Rick Rieder
  • uploads///Part  Graph
    Company & Industry Overviews

    Inside IHI’s Large-Caps: Becton Dickinson Rose on Good 2Q16

    Becton Dickinson (BDX) announced its 2Q16 earnings on May 5, 2016. Becton Dickinson closed at $160.43 and was trading above the 20-day moving average. The stock has risen 4.1% YTD.

    By Peter Neil
  • uploads///Part  Graph
    Company & Industry Overviews

    IHI Large-Caps: Baxter Launches Mobile Health App in India

    In a press release, Baxter International (BAX) announced that it has launched a new mobile app in India called Sisu Janani Seva. It’s also known as mHealth.

    By Peter Neil
  • uploads///integration goals
    Company & Industry Overviews

    Analyzing Medtronic’s Acquisition of Covidien

    Medtronic’s (MDT) acquisition of Covidien in January 2016 positioned the company as the biggest player in the medical device industry.

    By Sarah Collins
  • uploads///strategic initiatives
    Company & Industry Overviews

    Behind Becton Dickinson’s Strategic Restructuring and Business Consolidation

    To better position itself amid the changing medical device environment, Becton Dickinson has come to focus on restructuring and business model evolution.

    By Sarah Collins
  • uploads///Part  Graph
    Company & Industry Overviews

    IHI: Which of Its Holdings Was the Top Performer?

    In this article, we’ll analyze the YTD (year-to-date) performances of the top five holdings of the iShares US Medical Device ETF (IHI).

    By Peter Neil
  • uploads/// innovative ability
    Macroeconomic Analysis

    How Has Technology Influenced Process and Product Innovation?

    One of the most prominent effects of technology is on the asset side of the balance sheet. Many technologies drive companies to employ fewer assets in order to generate higher returns.

    By Rick Rieder
  • uploads///revenues
    Company & Industry Overviews

    How a Strong Product Portfolio Drives Thermo Fisher’s Valuations

    Thermo Fisher Scientific (TMO) registered sales of $4.7 billion, representing year-over-year growth of 4% in 4Q15 and fiscal 2015 sales of ~$17 billion.

    By Sarah Collins
  • uploads///segmentation
    Company & Industry Overviews

    An Overview of Thermo Fisher Scientific’s Business Model

    Thermo Fisher Scientific (TMO) has made a number of acquisitions over the years, resulting in the expansion of the company’s product portfolio with the inclusion of a number of premium brands.

    By Sarah Collins
  • uploads///analyst recommendations
    Earnings Report

    Latest Consensus Recommendation for Medtronic: Strong “Buy”

    Medtronic is set to release its fiscal 3Q16 earnings results on March 1, 2016. About 76.9% of companies have rated Medtronic as a “buy.”

    By Sarah Collins
  • uploads///analyst recommendations
    Earnings Report

    Becton, Dickinson and Company’s Latest Analyst Recommendations

    Becton, Dickinson and Company (BDX), or BD, is set to release its 1Q16 earnings results on February 3, 2016.

    By Sarah Collins
  • uploads///analyst recommendations
    Earnings Report

    Abbott Laboratories’ Latest Analyst Recommendations

    In a Bloomberg survey of 24 brokerage firms, as recorded on January 18, 2016, about 70.8% of firms have rated Abbott Laboratories a “buy,” and 29.2% of firms have rated the company a “hold.

    By Sarah Collins
  • uploads///revenue
    Company & Industry Overviews

    Thermo Fisher Scientific: A Leading Medical Technology Company

    Thermo Fisher Scientific (TMO) is one of the leading medical technology companies in the world, providing a broad portfolio of laboratory equipment and services.

    By Sarah Collins
  • uploads///established pharmaceutical business
    Company & Industry Overviews

    A Key Look at Abbott Laboratories’ Acquisitions and Divestments

    Inorganic growth through acquisitions has led to the expansion of Abbott Laboratories across geographies and to the broadening of its product portfolio.

    By Sarah Collins
  • uploads///ESTABLSIHED PHARMA GEOGRAPHIC SEGMENTATION
    Company & Industry Overviews

    Established Pharmaceuticals Segment of Abbott Laboratories

    Abbott’s Established Pharmaceuticals segment is a consumer-oriented segment with a consumer mix of around 75% self-pay consumers and 25% third-party payers.

    By Sarah Collins
  • uploads///valuation
    Company & Industry Overviews

    A Look at Becton, Dickinson and Company’s Valuation

    Becton, Dickinson and Company is one of the five biggest medical device companies in the United States.

    By Sarah Collins
  • uploads///abbotts history timeline
    Company & Industry Overviews

    Introducing Abbott Laboratories, a Leading Global Healthcare Company

    Abbott Laboratories operates across more than 150 countries, employs over 73,000 people, and is the global leader in the nutrition subsector.

    By Sarah Collins
  • uploads///revenue growth
    Company & Industry Overviews

    Becton, Dickinson and Company’s Acquisitions and Collaborations

    Becton, Dickinson and Company’s (BDX), or BD’s, growth strategy includes acquisitions and collaborations.

    By Sarah Collins
  • uploads///bds history timeline
    Company & Industry Overviews

    Becton, Dickinson and Company: A Leading Global Medical Device Company

    Becton, Dickinson and Company, or BD, headquartered in Franklin Lakes, New Jersey, is one of the leading medical technology companies in the United States.

    By Sarah Collins
  • uploads///latest technologies impacting medical device industry
    Company & Industry Overviews

    Why Technology Is a Key Driver in the US Medical Device Industry

    Traditionally, the United States has been home to the most advanced technological inventions in the medical device industry.

    By Sarah Collins
  • uploads///us  statistics
    Company & Industry Overviews

    How Economic and Demographic Factors Affect Medical Device Industry

    Though the medical device sector displays significant resilience towards changes in the economic environment, economic factors do impact short-term demand substantially.

    By Sarah Collins
  • uploads///medical device classifications
    Company & Industry Overviews

    What Are the Medical Device Approval Processes in Major Markets?

    In most countries, the approval process varies across different categories of devices classified as per their risk profiles.

    By Sarah Collins
  • uploads///physician emplyment dynamics v
    Company & Industry Overviews

    How the Dynamics Are Changing in the Medical Device Industry

    The medical device industry consists of a few big manufacturing companies that dominate the market and a large number of small players.

    By Sarah Collins
  • uploads///no
    Company & Industry Overviews

    Why Are Patents Necessary for Medical Device Companies?

    Medical device companies are driven by innovation and inventions that involve high research and development (or R&D) costs.

    By Sarah Collins
  • uploads///key components of Reimbursement
    Company & Industry Overviews

    How Reimbursement Models Impact the Medical Device Industry

    Coverage, coding, and payment are essential elements to obtaining adequate reimbursement for a new medical device.

    By Sarah Collins
  • uploads///COMPETITION IN US MEDICAL DEVICE INDUSTRY
    Company & Industry Overviews

    Analyzing the Competitive Landscape of the Medical Device Industry

    The medical device industry in the US consists of a few big players and a large number of small and medium enterprises.

    By Sarah Collins
  • uploads///global health expenditure
    Company & Industry Overviews

    How Is the US Medical Device Industry Performing in Emerging Markets?

    US medical device exports were worth $45 billion against the medical device industry’s global market value of $340 billion in 2014.

    By Sarah Collins
  • uploads///Regulation history
    Company & Industry Overviews

    How Does the FDA Classify Medical Devices?

    Medical devices are classified as per the level of control required by the Food, Drug, and Cosmetic Act (or FD&C Act).

    By Sarah Collins
  • uploads///pe valuation
    Company & Industry Overviews

    How Is the US Medical Device Industry Valued?

    The US medical device industry has rebounded sharply since its 2008 decline, and it is trading at a high PE of 21.9x.

    By Sarah Collins
  • uploads///etfs
    Company & Industry Overviews

    What Are the Major US Medical Device Industry ETFs?

    Funds like the Healthcare Select Sector SPDR ETF (or XLV) provide exposure of approximately 16% to the medical device industry.

    By Sarah Collins
  • uploads///medical value chain
    Company & Industry Overviews

    How Do Commodity Prices Impact the Medical Device Industry?

    Medical device manufacturers source various medical components and parts from suppliers in order to assemble or develop medical devices.

    By Sarah Collins
  • © Copyright 2022 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.